UFP Technologies Inc

Latest Results (12.10.2025):

UFP Technologies Inc. reported record-breaking financial results for the first quarter of 2025, demonstrating significant growth in revenue, operating income, and net income compared to the same period in 2024. The company's strategic initiatives and strong performance in the MedTech sector have been key drivers of this success.

Revenue Growth

UFP Technologies Inc. achieved a 41.1% increase in sales, reaching $148.1 million in Q1 2025 compared to $105.0 million in Q1 2024. Sales to the medical market surged by 50.4%, highlighting robust demand across various MedTech segments.

Net Income Increase

The company's net income rose by 35.4% to $17.2 million in Q1 2025, up from $12.7 million in the first quarter of the previous year. Earnings per share also saw a significant increase, reaching $2.21 compared to $1.64.

Strong MedTech Performance

UFP Technologies' MedTech business experienced a remarkable 50% growth, driven by high demand in the Safe Patient Handling space. Other segments such as Interventional and Surgical, Infection Prevention, Orthopedics, and Advanced Wound Care each grew by over 25%, underscoring the company's diversified strength within the medical sector.

Strategic Expansion and Acquisitions

The company executed a key agreement granting exclusive manufacturing rights for its Safe Patient Handling business through June 2030 and expanded its manufacturing operations in the Dominican Republic. Additionally, recent acquisitions have enhanced UFP Technologies' manufacturing capacity and talent pool, supporting continued growth and meeting increasing customer demand.

Financial Health and Efficiency

Operating income increased by 45.2% to $23.1 million, while adjusted EBITDA grew by 45.9% to $30.2 million in Q1 2025. Despite a slight decrease in gross margin to 28.5%, the company effectively managed its SG&A expenses, which decreased as a percentage of sales, reflecting improved operational efficiency.